Nobelis Group cholesterol-lowering food supplement red box
Nobelis Group cholesterol-lowering food supplement red box
Couldn't load pickup availability
Dimefar Food Supplement – Capsules – Nobélis SASU Group – Nutritional Supplement
The Dimefar dietary supplement in capsule format is a nutritional supplement developed by Groupe Nobélis SASU, designed to support the daily intake of essential micronutrients. This product is intended for people wishing to maintain their vitality and promote the proper functioning of their body, as part of a balanced diet and a healthy lifestyle.
- Contributes to maintaining energy metabolism thanks to the presence of selected vitamins and minerals.
- Supports the normal functioning of the immune system as recommended in the official leaflet.
- Helps reduce the feeling of fatigue, as indicated on the active ingredients.
Official information regarding the method of use is not available. It is recommended to consult the package insert for the dosage, method of administration and precautions for use specific to this Dimefar food supplement.
Official information regarding the composition is not available. For the full list of ingredients, see package insert.
Legal notices:
The information presented is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the Consumer Code.
They do not constitute a medical prescription nor do they replace consultation with a qualified healthcare professional. Any use of the product must comply with the instructions, the recommended dosage and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, liability cannot be incurred in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and subject to change at any time. Users are encouraged to regularly check for updates or contact a healthcare professional with any treatment-related questions.
